|
FGD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.657900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.443800E-01 |
| Normal-vs-Stage2 |
2.215800E-01 |
| Normal-vs-Stage3 |
4.878200E-03 |
| Normal-vs-Stage4 |
2.997600E-01 |
| Stage1-vs-Stage2 |
8.569500E-02 |
| Stage1-vs-Stage3 |
2.703900E-03 |
| Stage1-vs-Stage4 |
2.464200E-01 |
| Stage2-vs-Stage3 |
9.159800E-02 |
| Stage2-vs-Stage4 |
6.155800E-01 |
| Stage3-vs-Stage4 |
5.592000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.687800E-01 |
| Normal-vs-AfricanAmerican |
1.806990E-01 |
| Normal-vs-Asian |
5.427400E-01 |
| Caucasian-vs-AfricanAmerican |
5.317400E-01 |
| Caucasian-vs-Asian |
7.253800E-01 |
| AfricanAmerican-vs-Asian |
9.009600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.923800E-01 |
| Normal-vs-Female |
6.94060000028252E-07 |
| Male-vs-Female |
1.25440000053878E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.523000E-01 |
| Normal-vs-Extreme_Weight |
8.612200E-01 |
| Normal-vs-Obese |
5.060100E-02 |
| Normal-vs-Extreme_Obese |
9.245000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.256600E-01 |
| Normal_Weight-vs-Obese |
5.561400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.086400E-01 |
| Extreme_Weight-vs-Obese |
5.943800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.870800E-01 |
| Obese-vs-Extreme_Obese |
2.361000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.682100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.961100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.136200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.627600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.884500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.997560E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.203800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.963900E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.979600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.513800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.526000E-01 |
| Normal-VS-Type2 PRCC |
4.658600E-01 |
| Normal-VS-KIRP CIMP |
3.73310000000293E-05 |
| Normal-VS-Unclassified PRCC |
3.163800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.905600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.66133814775094E-16 |
| Type1 PRCC-VS-Unclassified PRCC |
2.894200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.08220099548362E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
1.714330E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.70680000028045E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.290400E-01 |
| Normal-vs-N1 |
2.615800E-03 |
| Normal-vs-N2 |
3.078200E-02 |
| N0-vs-N1 |
7.563700E-03 |
| N0-vs-N2 |
1.394800E-04 |
| N1-vs-N2 |
1.766000E-01 |
|
|
